{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T02:27:37Z","timestamp":1770517657445,"version":"3.49.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.mehy.2020.109756","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T11:42:52Z","timestamp":1587555772000},"page":"109756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?"],"prefix":"10.1016","volume":"140","author":[{"given":"Gokhan","family":"Sargin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sare \u0130lknur","family":"Yava\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irfan","family":"Yavasoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2020.109756_b0005","unstructured":"https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports."},{"key":"10.1016\/j.mehy.2020.109756_b0010","unstructured":"https:\/\/www.who.int\/news-room\/feature-stories\/detail\/world-malaria-report-2019."},{"key":"10.1016\/j.mehy.2020.109756_b0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11427-020-1637-5","article-title":"Evolution of the novel coronavirus fromthe ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission","volume":"63","author":"Xu","year":"2020","journal-title":"Sci. China Life Sci."},{"issue":"140","key":"10.1016\/j.mehy.2020.109756_b0020","article-title":"Renin-angiotensin system: the unexpected flaw inside the human immune system revealed by SARS-CoV-2","volume":"21","author":"Roncati","year":"2020","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.mehy.2020.109756_b0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.mehy.2020.109756_b0030","article-title":"COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression","volume":"20","author":"Zhou","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.mehy.2020.109756_b0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13054-020-2818-6","article-title":"Treatment of COVID-19: old tricks for new challenges","volume":"24","author":"Cunningham","year":"2020","journal-title":"Crit. Care"},{"key":"10.1016\/j.mehy.2020.109756_b0040","article-title":"New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?","volume":"11","author":"Devaux","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.mehy.2020.109756_b0045","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/results?cond=hydroxychloroquine+corona."},{"key":"10.1016\/j.mehy.2020.109756_b0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.mehy.2020.109756_b0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.injr.2015.04.001","article-title":"Antimalarials in rheumatology: expanding therapeutic Armamentarium","volume":"10","author":"Thabah","year":"2015","journal-title":"Indian J. Rhuematol."},{"key":"10.1016\/j.mehy.2020.109756_b0060","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40261-018-0656-y","article-title":"Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases: a mini-review","volume":"38","author":"Plantone","year":"2018","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.mehy.2020.109756_b0065","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jfo.2017.08.002","article-title":"Update on recommendations for screening for hydroxychloroquine retinopathy","volume":"40","author":"Couturier","year":"2017","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.mehy.2020.109756_b0070","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijantimicag.2007.05.015","article-title":"Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century","volume":"30","author":"Rolain","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.mehy.2020.109756_b0075","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(16)00230-0","article-title":"The path to eradication: a progress report on the malaria-eliminating countries","volume":"387","author":"Newby","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.mehy.2020.109756_b0080","unstructured":"http:\/\/aplma.org\/blog\/22\/asia-pacific-at-the-forefront-of-a-global-movement-to-eliminate-malaria\/."},{"key":"10.1016\/j.mehy.2020.109756_b0085","unstructured":"United Nations. 2015. African Leaders Call for Elimination of Malaria by 2030. Office of the UN Secretary-General\u2019s Special Envoy for Financing the Health Millennium Development Goals and for Malaria. MDG Health Envoy-News, February 3."},{"key":"10.1016\/j.mehy.2020.109756_b0090","unstructured":"Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, Arrow KJ, Panosian C, Gelband H, eds.Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. Washington (DC): National Academies Press (US); 2004."},{"key":"10.1016\/j.mehy.2020.109756_b0095","first-page":"205","article-title":"Antimalarial drug policy in India: past, present & future","volume":"139","author":"Anvikar","year":"2014","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.mehy.2020.109756_b0100","first-page":"175","article-title":"Resistance to chloroquine in falciparum malaria in Assam state, India","volume":"5","author":"Sehgal","year":"1973","journal-title":"J. Commun. Dis"},{"key":"10.1016\/j.mehy.2020.109756_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/heapol\/16.1.1","article-title":"The challenge of chloroquine-resistant malaria in sub-Saharan Africa","volume":"16","author":"Nuwaha","year":"2001","journal-title":"Health Policy Plan."},{"key":"10.1016\/j.mehy.2020.109756_b0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1475-2875-10-116","article-title":"Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data","volume":"10","author":"Frosch","year":"2011","journal-title":"Malar J."},{"key":"10.1016\/j.mehy.2020.109756_b0115","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1475-2875-10-326","article-title":"Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries","volume":"10","author":"O'Connell","year":"2011","journal-title":"Malar J."},{"key":"10.1016\/j.mehy.2020.109756_b0120","series-title":"Guidelines for Diagnosis and Treatment of Malaria in India","author":"National Institute of Malaria Research (NIMR)","year":"2011"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720306587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987720306587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:23:27Z","timestamp":1759692207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987720306587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":24,"alternative-id":["S0306987720306587"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109756","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.109756","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109756"}}